Rivulet Media Inc (fka RIVU)

[sizzleweed]

Or from spinning off a new company. he had to have the books settled and no Lis Pendens . The same folks saying the same lame things over and over.

Reykjavik Eros Garmisch Ensenada Natal

HemaXellerate II™
[Regen BioPharma is currently in the preclinical stage of development for HemaXellerate II

HemaXellerate II is intended to be a universal donor endothelial cell based therapeutic and is intended to be manufactured by obtaining cells from a part of the placenta called the “vascular lobules”. The cells are processed and utilized for the purpose of stimulating bone marrow hematopoetic stem cell repair and proliferation. The mechanism of action for HemaXellerate II is similar to HemaXellerate I whereby the harvested and processed cells would produce growth factors which would mediate the therapeutic effects of the product.